Alliance A022101: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer - evaluating radiation, ablation, and surgery (ERASur)
- Citation:
- Int J Rad Oncol Biol Phys vol 117 (2 suppl) abstr E335
- Meeting Instance:
- ASTRO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Paul B. Romesser Eric D. Miller Qian Shi Jesse G. Dixon Sepideh Gholami Sarah B. White Christina Wu Christopher C. Goulet Kyung-Wook Jee Chadwick L. Wright Rona Yaeger Ardaman Shergill Theodore S. Hong Thomas J. George Eileen M. O'Reilly Jeffrey A. Meyerhardt Kathryn E. Hitchcock
- Networks:
- LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NY016, LAPS-WI013, MONTANA, NJ032, NORTHWELL, OH070
- Study
- Alliance-A022101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: